The Impact of COPD and Smoking History on the Severity of COVID-19
Author(s): Havish Odugula VSS, Sarika Dakhode* and Ashok Mehendale
Abstract
Patients with chronic obstructive pulmonary disease (COPD) are particularly vulnerable to respiratory tract infections causing respiratory exacerbations. There is no enough evidence to say either it are at higher risk of COVID infection or its complications like severe pneumonia or death. The study's purpose is to examine if COPD is linked to bad outcomes of COVID19 like hospitalization, or death due to COVID19. COVID-19 development and prognosis are both exacerbated by chronic obstructive pulmonary disease and a history of smoking. Many who smoke are so much more susceptible to respiratory infections. Smoking can enhance the activity of ACE-2 receptor, which would be recognized as site for both the SARS-CoV2 and NL638 which are two human respiratory coronaviruses. This is also true for latest electronic devices used for smoking that "heat instead of burn, “such as electronic cigarettes and IQOS devices. Virus -causing Covid-19 adheres to ACE2 receptor. On all the cases of Covid-19 that have been detected, Smoking status data should be gathered. Transmission of corona virus and death due to COVID19 is being influenced by smoking has gotten little attention. In addition to influenza and bacterial pneumonia, smokers are more likely to get tuberculosis. Patients are more susceptible to bacterial and viral pulmonary infections as a result of the damage induced by smoking to the lungs. The flu is 34 percent more likely to strike smokers than nonsmokers. In developed countries, smoking is the leading cause of chronic obstructive pulmonary disease (COPD), However, air pollution and decrease in quality of air are leading cause in emerging countries.